Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

CT and Angiography Agreement in Patients from the ISCHEMIA Trial

Computed tomographic (CT) angiography showed a high degree of agreement with conventional angiography to detect significant coronary artery disease and rule out left main disease.

tomografía y la angiografía ISCHEMIA

This imaging study was done on a group of patients before their randomization in the ISCHEMIA trial.

Data are soon to be published in JACC Cardiovascular Imaging and add plenty of evidence in favor of non-invasive diagnosis.

The rise of CT scans came about to solve the opposite problem. In this sense, its high negative predictive value prompted its use to rule out coronary artery disease in patients with unconvincing functional studies.

The power of CT vs. angiography in patients with high ischemic burden in functional assessments plus high probability of coronary artery disease had not been tested yet.

A “blinded” CT was performed before randomization to exclude the opposite ends of coronary artery disease—i.e., left main coronary artery and coronary arteries without lesion.

Randomization then defined the initial strategy, either conservative or invasive (the latter guided by angiography and optimum revascularization).


Read also: Post MI Betablockers for Good?


All lesions ≥50% were defined as anatomically significant.

Lesion in at least one vessel and lack of left main coronary artery lesions were detected by CT in about 1728 patients.

Conventional angiography confirmed the lack of left main coronary artery lesions in 97.1% of cases, and lesions in at least one vessel in 92.2% of cases. Only in 4.9% of patients did angiography not show significant lesions.


Read also: TAVR vs. the Least Invasive Surgically Implanted Valve.


Using a 70%—instead of 50%—stenosis diameter modified this excellent diagnostic precision.

Conclusion

CT showed an excellent agreement with angiography to identify patients with significant coronary artery lesions and rule out left main disease.

j-jcmg-2020-11-012free

Original Title: Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial.

Reference: G.B. John Mancini et al. J Am Coll Cardiol Img 2021, article in press. https://doi.org/10.1016/j.jcmg.2020.11.012.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...